FDA: Drugmakers have not made good on promised studies

04/24/2008 | Bloomberg1

A federal report found that drugmakers, as of Sept. 30, had not begun 1,044 post-market drug studies that they pledged to the FDA they would perform. Promises for 444 of them date back to Oct. 1, 2004, or earlier. A spokeswoman for the FDA said it will make sure that drug firms finish the incomplete post-approval trials "in a timely manner."

View Full Article in:

Bloomberg1

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC